ABH Healthcare Ltd.
SMEBSE₹96–102
₹ 35 Cr
2400 Shares
₹ 2,30,400
₹10
Financial Summary
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| 5,250.69 | 4,926.71 | |
| 8.35 | 5.02 | |
| 5,259.04 | 4,931.73 | |
| 3,779.04 | 3,607.2 | |
| 793.07 | 743.02 | |
| 563.94 | 534.7 |
Subscription Details
IPO Timeline
IPO Offer Start
24 Aug 2026
IPO Offer Ends
27 Aug 2026
1 Sept 2026
Use of Proceeds
| # | Purpose | Amount (₹ Million) |
|---|---|---|
| 1 | Repayment/prepayment, in part or full, of certain of our borrowings | 170 |
| 2 | Funding our working capital requirements | 50 |
Promoters
Book Running Lead Managers
Promoter Shareholding
Pre-IPO
100.00%
Promoter stake
Post-IPO
69.99%
Promoter stake
Offered to Public
34,29,600
shares
Post Share Capital
79,99,996
shares
About the Company
We have adopted comprehensive information technology ecosystem aimed at transforming both the patient and clinicalexperience, as well as boosting the business and operational efficiency. Central to our strategy is the adoption of cutting-edgetechnologies, including digitalizing our patient experience through our patient portal, website and widely-used messagingplatforms. We have also implemented a state-of-the-art Computerized Physician Order Entry (CPOE) system and ElectronicHealth Record (EHR) platform, licensed from a third-party service provider.
Use of Proceeds
(i) Repayment / prepayment, in part or full, of certain of our borrowings;(ii) Funding our Working Capital Requirements; and(iii) Funding inorganic growth through unidentified acquisitions and general corporate purposes